The effect of lysed platelets on neutralization of heparin in vitro with protamine as measured by the activated coagulation time (ACT)

A. P. Bode, W. J. Castellani, E. D. Hodges, S. Yelverton

Research output: Contribution to journalArticlepeer-review

12 Scopus citations

Abstract

The effect of lysed platelets on the activated coagulation time (ACT) was studied in heparinized whole blood during titration with protamine. Frozen-thawed washed platelet suspension, or a chromatography fraction thereof, or autologous frozen-thawed platelet-rich plasma was added in various dilutions to freshly drawn blood anticoagulated with 3,000 USP units/l heparin. After a 10 min incubation, the amount of protamine needed to restore the ACT to baseline ('protamine titration dose') was determined. We found that the protamine titration dose decreased in proportion to the amount of lysed platelet material added; expressed as a percentage of the total number of platelets present, each unit increase in lysed platelets produced a 1.7% ± 0.8 (SD) reduction in the protamine dose needed to normalize the ACT. A heparin activity assay showed that this effect was not due to anti-heparin activity of lysed platelets such as platelet factor 4 (PF4). Our data indicate that the procoagulant activity of platelet membranes reduced the sensitivity of the ACT to heparin. These findings suggest that membranous platelet microparticles may cause an inaccurate calculation, based on the ACT, of a protamine dose to reverse heparin anticoagulation in cardiopulmonary bypass procedures.

Original languageEnglish (US)
Pages (from-to)213-217
Number of pages5
JournalThrombosis and Haemostasis
Volume66
Issue number2
DOIs
StatePublished - 1991

All Science Journal Classification (ASJC) codes

  • Hematology

Fingerprint Dive into the research topics of 'The effect of lysed platelets on neutralization of heparin in vitro with protamine as measured by the activated coagulation time (ACT)'. Together they form a unique fingerprint.

Cite this